BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1327 related articles for article (PubMed ID: 11175850)

  • 1. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.
    Skobe M; Hawighorst T; Jackson DG; Prevo R; Janes L; Velasco P; Riccardi L; Alitalo K; Claffey K; Detmar M
    Nat Med; 2001 Feb; 7(2):192-8. PubMed ID: 11175850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
    Tobler NE; Detmar M
    J Leukoc Biol; 2006 Oct; 80(4):691-6. PubMed ID: 16793912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.
    Roberts N; Kloos B; Cassella M; Podgrabinska S; Persaud K; Wu Y; Pytowski B; Skobe M
    Cancer Res; 2006 Mar; 66(5):2650-7. PubMed ID: 16510584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
    Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of VEGF-A/VEGF-C antisense oligodeoxynucleotide on angiogenesis, lymphangiogenesis, and tumor growth of breast cancer].
    Chen JS; Zhang YJ; Hu SE; Zhang HQ
    Ai Zheng; 2007 Sep; 26(9):972-6. PubMed ID: 17927855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [VEGF-C, VEGF-D and VEGF-receptor 3: novel key regulators of lymphangiogenesis and cancer metastasis].
    Wissmann C; Höcker M
    Z Gastroenterol; 2002 Sep; 40(9):853-6. PubMed ID: 12215955
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model.
    Shibata MA; Morimoto J; Shibata E; Otsuki Y
    Cancer Gene Ther; 2008 Dec; 15(12):776-86. PubMed ID: 18654613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model.
    Kawakami M; Yanai Y; Hata F; Hirata K
    Surg Today; 2005; 35(2):131-8. PubMed ID: 15674494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
    Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P
    Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival.
    Schoppmann SF; Fenzl A; Nagy K; Unger S; Bayer G; Geleff S; Gnant M; Horvat R; Jakesz R; Birner P
    Surgery; 2006 Jun; 139(6):839-46. PubMed ID: 16782443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
    Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
    BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein.
    Zhang D; Li B; Shi J; Zhao L; Zhang X; Wang C; Hou S; Qian W; Kou G; Wang H; Guo Y
    Cancer Res; 2010 Mar; 70(6):2495-503. PubMed ID: 20197464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice.
    Yanai Y; Furuhata T; Kimura Y; Yamaguchi K; Yasoshima T; Mitaka T; Mochizuki Y; Hirata K
    J Exp Clin Cancer Res; 2001 Sep; 20(3):419-28. PubMed ID: 11718224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphangiogenesis and tumor metastasis.
    Pepper MS; Tille JC; Nisato R; Skobe M
    Cell Tissue Res; 2003 Oct; 314(1):167-77. PubMed ID: 12883995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
    Mattila MM; Ruohola JK; Karpanen T; Jackson DG; Alitalo K; Härkönen PL
    Int J Cancer; 2002 Apr; 98(6):946-51. PubMed ID: 11948478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.
    Karpanen T; Egeblad M; Karkkainen MJ; Kubo H; Ylä-Herttuala S; Jäättelä M; Alitalo K
    Cancer Res; 2001 Mar; 61(5):1786-90. PubMed ID: 11280723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.